Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response

BACKGROUND: Pegylated (PEG)-interferon (IFN)-alfa-2a plus ribavirin (RBV) therapy for 24 weeks is now a standard treatment protocol for patients with hepatitis C virus (HCV) genotype 2. As RBV cannot be used in certain situations, we examined whether PEG-IFN-alfa-2a monotherapy for 24 weeks or less...

Descripción completa

Detalles Bibliográficos
Autores principales: Etoh, Reiko, Imazeki, Fumio, Kurihara, Tomoko, Fukai, Kenichi, Fujiwara, Keiichi, Arai, Makoto, Kanda, Tatsuo, Mikata, Rintaro, Yonemitsu, Yutaka, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224591/
https://www.ncbi.nlm.nih.gov/pubmed/21884572
http://dx.doi.org/10.1186/1756-0500-4-316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224591/
https://www.ncbi.nlm.nih.gov/pubmed/21884572
http://dx.doi.org/10.1186/1756-0500-4-316

Ejemplares similares